Results 141 to 150 of about 804,884 (247)
Options for global tobacco control beyond the Framework Convention in Tobacco Control [PDF]
Gartner, Coral, McNeill, Ann
openaire +4 more sources
Abstract RBN‐3143 is an inhibitor of PARP14 in development for inflammatory diseases. Multiple assessments were conducted to evaluate the clinical pharmacology properties of RBN‐3134. A randomized, double‐blind, placebo‐controlled study assigned healthy volunteers (HVs) to single ascending doses (SADs) (25‐1000 mg) or multiple ascending doses (MADs ...
Thomas M. Polasek+9 more
wiley +1 more source
Tobacco Control Policy in India: Progress and Challenges Quantified Using the Tobacco Control Scale. [PDF]
Chengappa KS+5 more
europepmc +1 more source
Clinical inhibition and genetic variation of the Breast Cancer Resistance Protein (BCRP/ABCG2) efflux transporter can significantly influence drug exposure, highlighting the need for reliable BCRP functional biomarkers. This study aimed to identify and evaluate biomarkers predictive of BCRP function in humans.
Andrew M. Riselli+16 more
wiley +1 more source
Addressing the urgent need for tobacco control among adolescents. [PDF]
Shivale SJ, Madamanchi D.
europepmc +1 more source
Burley tobacco clubs in Malawi : nonmarket institutions for exports [PDF]
This paper studies nonmarket institutions that facilitate exports. In Malawi, as in many other developing countries, farmers face numerous constraints that disconnect them from export markets.
Negri, Mariano, Porto, Guido G.
core
Over 10 million children in the world have epilepsy, with an unknown cause in half of the cases. The gut microbiome has been associated with various neurological disorders, and certain drugs greatly disturb the microbiome. Our aim was to study the association of prenatal and childhood exposure (before the age of two) to antibiotics, proton pump ...
Unnur Gudnadottir+4 more
wiley +1 more source
Correction: Conducting tobacco control surveys among schoolchildren in Bangladesh, India and Pakistan: A feasibility study. [PDF]
Mishu MP+23 more
europepmc +1 more source
Lysergic acid diethylamide (LSD) is currently being investigated as a potential treatment for psychiatric and neurological disorders. Different LSD formulations (base or tartrate, oral or intravenous) are being used. Unclear is whether LSD base and tartrate pharmacokinetics are equivalent.
Denis Arikci+7 more
wiley +1 more source